Evaluation of medicinal products indicated for treatment of bacterial infections - Scientific guideline
Opinion/decision on a Paediatric investigation plan (PIP): Tenkasi (previously Orbactiv), oritavancin (diphosphate), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Skin and subcutaneous tissue disorders, PIP number: P/0074/2024
Opinion/decision on a Paediatric investigation plan (PIP): Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron), Dinutuximab beta, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0076/2024
Product-information (QRD) templates - Human
Quality Review of Documents (QRD) annotated template v11: Draft for public consultation
Quality Review of Documents (QRD) annotated template v11: Draft for public consultation - track changes
Opinion/decision on a Paediatric investigation plan (PIP): Lokelma, sodium zirconium cyclosilicate, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: P/0077/2024
The EFIM Telemedicine Working Group is pleased to invite you to our upcoming webinar on the Digital Transformation of Clinical Reasoning in Internal Medicine, taking place on Wednesday, 8 May from 18:00 to 19:30 CET.
Chaired by Dr. Ismael Said Criado, Chair of the EFIM Telemedicine Working Group, this session will explore how digital innovation is reshaping clinical decision-making processes, and supporting internal medicine professionals in daily practice.
Speakers:
EMEA-001579-PIP01-13-M06
EMEA-002338-PIP04-23